@Jonathan Edwards
Prof Edwards,
Apologies if this has already been discussed, but I'm wondering:
Since Epstein-Barr virus resides in B-cells (if I understand this correctly), does Rituximab extinguish an active or re-activating EBV?
I know this mechanism is not likely to be the cause of the response in ME patients given Rituximab, since the delayed response indicates an autoimmune mechanism, but all the same: if a patient with an active or re-activated EBV infection was given Rituximab, would they be cleared of the EBV?
Many thanks in advance! Your participation in the discussions here is much appreciated.
Prof Edwards,
Apologies if this has already been discussed, but I'm wondering:
Since Epstein-Barr virus resides in B-cells (if I understand this correctly), does Rituximab extinguish an active or re-activating EBV?
I know this mechanism is not likely to be the cause of the response in ME patients given Rituximab, since the delayed response indicates an autoimmune mechanism, but all the same: if a patient with an active or re-activated EBV infection was given Rituximab, would they be cleared of the EBV?
Many thanks in advance! Your participation in the discussions here is much appreciated.